Antiphospholipid syndrome
Clinical trials for Antiphospholipid syndrome explained in plain language.
Never miss a new study
Get alerted when new Antiphospholipid syndrome trials appear
Sign up with your email to follow new studies for Antiphospholipid syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood clot drug trial for rare autoimmune disease pulled before start
Disease control CancelledThis study aimed to test if crovalimab, added to standard blood thinners, could prevent dangerous blood clots in people with antiphospholipid syndrome (APS). APS is an autoimmune disease that increases clot risk. The trial was withdrawn before enrolling any participants, so no re…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a common antiplatelet drug replace warfarin after APS-Related stroke?
Prevention OngoingAntiphospholipid syndrome (APS) raises the risk of blood clots and strokes, and doctors often prescribe warfarin to prevent another stroke. Warfarin requires frequent blood tests and carries bleeding risks, especially for younger patients. This trial compares clopidogrel-based an…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase 4 • Sponsor: Seoul National University Hospital • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
New MRI study seeks hidden stroke causes in rare blood disorder
Knowledge-focused By invitation onlyThis study looks at why people with antiphospholipid syndrome (APS) — a condition that raises blood clot risk — may have narrowed brain arteries. Researchers will use advanced MRI scans on 60 APS patients to check for artery narrowing and plaque buildup. The goal is to better und…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Rare disease pregnancy study pulled before it began
Knowledge-focused CancelledThis study was designed to track pregnancies in women with rare autoimmune and systemic diseases to understand complications and improve care. It planned to enroll women with conditions like lupus, rheumatoid arthritis, and scleroderma. However, the study was withdrawn before any…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC